In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
about
A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in PregnancyAntiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box.Ketolide agents HMR 3004 and HMR 3647 (telithromycin) inhibit the growth of Plasmodium falciparum in vitro.New insight-guided approaches to detect, cure, prevent and eliminate malaria.Several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, are new anti-malarial agents.
P2860
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
@ast
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
@en
type
label
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
@ast
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
@en
prefLabel
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
@ast
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
@en
P2093
P2860
P356
P1476
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species
@en
P2093
Eric Ekland
Ian Bathurst
J Carl Craft
Julie Lotharius
Prabhavathi Fernandes
P2860
P304
P356
10.1128/AAC.05039-11
P407
P577
2011-11-14T00:00:00Z